scholarly journals Not in My Back Yard: A Comparative Analysis of Crime Around Publicly Funded Drug Treatment Centers, Liquor Stores, Convenience Stores, and Corner Stores in One Mid-Atlantic City

2016 ◽  
Vol 77 (1) ◽  
pp. 17-24 ◽  
Author(s):  
C. Debra M. Furr-Holden ◽  
Adam J. Milam ◽  
Elizabeth D. Nesoff ◽  
Renee M. Johnson ◽  
David O. Fakunle ◽  
...  
Addiction ◽  
2001 ◽  
Vol 96 (8) ◽  
pp. 1149-1160 ◽  
Author(s):  
Dennis M. Donovan ◽  
David B. Rosengren ◽  
Lois Downey ◽  
Gary B. Cox ◽  
Kevin L. Sloan

2019 ◽  
Vol 49 ◽  
pp. 141-143
Author(s):  
Tsiskarishvili N. ცისკარიშვილი ნ. ◽  
Katsitadze A. კაციტაძე ა. ◽  
Tsiskarishvili N. ცისკარიშვილი ნ. ◽  
Tsiskarishvili Ts. ცისკარიშვილი ც. ◽  
Chitanava L. ჭითანავა ლ.

The paper presents the modern data concerning the spectrum of electromagnetic radiation and its impact on the structure and function of the skin at various dermatoses. The possibilities of non-drug treatment of dermatoses using different UV spectrum are described. Particular attention is paid to the study of the most effective and safe method for treatment by means of narrow-wave phototherapy with a maximum emission at a wavelength of 311 nm (UVB - 311). The results of the comparative analysis of efficacy and safety of PUVA photochemotherapy and phototherapy UVB -311, on examples of some specific nosologic units (psoriasis, parapsoriasis, vitiligo, mycosis fungoides, photodermatosis, atopic dermatitis)  are presented. Based on analysed data, authors conclude that UVB -311 nm is an effective, well-tolerated, safe and alternative method for treatment of chronic dermatoses.  The brief review of the available in literature data, allow authors to make conclusion about the possibility of widespread implementation of phototherapy method in practical dermatology.


2012 ◽  
Vol 6 ◽  
pp. SART.S8561 ◽  
Author(s):  
Jane Anne Fischer ◽  
Alexandra Marie Clavarino ◽  
Jackob Moses Najman

Context Little is known about the proportion of the Australian population using alcohol or other drugs who may seek treatment. There is a need to have some additional estimates of population morbidity which reflect harms associated with use. Objective To determine Australian population rates of publicly funded community based specialised alcohol and other drug treatment and in-patient hospital care by those ‘at risk’, by drug type, sex and age. Design and setting The design is secondary data analysis of publicly available datasets. We use the latest available complete data on Australian general population incidence of alcohol, cannabis amphetamines and ecstasy use (2007 National Drug Strategy Household Survey) and nationally collected administrative data on publicly funded specialised alcohol and other drug treatment services (2006–2007 Alcohol and Other Drug Treatment Services National Minimum Dataset) and public hospitals (2006–2007 National Hospital Morbidity Minimum Dataset) to calculate rates of drug treatment and in-patient hospital care per 1000 Australians. ‘At risk’ for alcohol is defined as being at risk of short term harm, as defined by the National Health and Medical Research Council (2001). ‘At risk’ for illicit drugs is defined as those exposed to potential harm through at least weekly use of cannabis, amphetamines and ecstasy use. Results Risky alcohol consumption followed by recent cannabis use appears to lead to most harm. Greater harm seems to be experienced by males rather than females. Younger adults (15–19 years) and older adults (40+ years) seem also to experience the highest rates of harm. Conclusions It is possible to derive population estimates of harms associated with licit and illicit drugs use. Treatment rates vary across drug type, gender and age. Alcohol and cannabis are the substances whose use leads to the greatest demand for services. Ecstasy appears to generate few presentations for treatment. Publicly available data can be used to estimate harms associated with the use of particular substances. Such estimates are best interpreted in the light of other ways of estimating harms.


2020 ◽  
pp. tobaccocontrol-2019-055577
Author(s):  
Joanne D'Silva ◽  
Joanne Moze ◽  
John H. Kingsbury ◽  
Rebecca K Lien ◽  
Christine M Matter ◽  
...  

BackgroundIn 2017 and 2018, Minneapolis, St. Paul, Duluth and Falcon Heights, Minnesota were among the first US cities to restrict the sale of menthol tobacco to adult-only stores. The study examined changes in the availability and marketing of these products following policy implementation.MethodsRetail store audits were conducted approximately 2 months pre-policy and post-policy implementation. Tobacco retail stores (n=299) were sampled from tobacco licensing lists in Minneapolis, St. Paul, Duluth and Falcon Heights, as well as six comparison cities without menthol policies. The presence of menthol tobacco was assessed, along with the number of interior and exterior tobacco ads and promotions at each store.ResultsThe majority of policy intervention stores (grocery, convenience stores and pharmacies) were compliant (Minneapolis, 84.4%; Duluth, 97.5%; and St. Paul and Falcon Heights, 100.0%) and did not sell menthol tobacco. In contrast, menthol tobacco was available in all comparison city stores, and most (96.0%) exempted tobacco shops and liquor stores post-policy implementation. Two Minneapolis convenience stores added interior tobacco shops, allowing them to continue selling menthol tobacco. Significant decreases in menthol tobacco marketing post-policy were observed in the stores’ interior in Minneapolis, St. Paul and Duluth (p<0.001) and on the stores’ exterior in Duluth (p=0.023).ConclusionsFindings demonstrate high rates of compliance, indicating that sales restrictions can significantly reduce the availability of menthol tobacco. However, challenges to policy adherence underscore the need for continued monitoring and enforcement action.


Sign in / Sign up

Export Citation Format

Share Document